Your browser doesn't support javascript.
loading
Identification of Regorafenib Prognostic Index (REP Index) via Recursive Partitioning Analysis in Patients with Advanced Hepatocellular Carcinoma Receiving Systemic Treatment: A Real-World Multi-Institutional Experience.
Rimini, Margherita; Yoo, Changhoon; Lonardi, Sara; Masi, Gianluca; Granito, Alessandro; Bang, Yeonghak; Rizzato, Mario Domenico; Vivaldi, Caterina; Ielasi, Luca; Kim, Hyung-Don; Bergamo, Francesca; Salani, Francesca; Leoni, Simona; Ryoo, Baek-Yeol; Ryoo, Min-Hee; Burgio, Valentina; Cascinu, Stefano; Casadei-Gardini, Andrea.
Afiliação
  • Rimini M; Department of Medical Oncology, Hospital Policlinico of Modena, Via Del Pozzo n.71, 41122, Modena, Italy. margherita.rimini@gmail.com.
  • Yoo C; Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea.
  • Lonardi S; Early Phase Clinical Trial Unit, Department of Oncology, Veneto Institute of Oncology IOV-IRCCS, Padua, Italy.
  • Masi G; Medical Oncology Unit 1, Department of Oncology, Veneto Institute of Oncology IOV-IRCCS, Padua, Italy.
  • Granito A; U.O. Oncologia Medica 2 Universitaria Azienda Ospedaliero-Universitaria Pisana, Pisa, Italy.
  • Bang Y; Department of Medical and Surgical Sciences, University of Bologna, Bologna, Italy.
  • Rizzato MD; Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea.
  • Vivaldi C; Medical Oncology Unit 1, Department of Oncology, Veneto Institute of Oncology IOV-IRCCS, Padua, Italy.
  • Ielasi L; U.O. Oncologia Medica 2 Universitaria Azienda Ospedaliero-Universitaria Pisana, Pisa, Italy.
  • Kim HD; Department of Medical and Surgical Sciences, University of Bologna, Bologna, Italy.
  • Bergamo F; Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea.
  • Salani F; Medical Oncology Unit 1, Department of Oncology, Veneto Institute of Oncology IOV-IRCCS, Padua, Italy.
  • Leoni S; U.O. Oncologia Medica 2 Universitaria Azienda Ospedaliero-Universitaria Pisana, Pisa, Italy.
  • Ryoo BY; Department of Medical and Surgical Sciences, University of Bologna, Bologna, Italy.
  • Ryoo MH; Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea.
  • Burgio V; Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea.
  • Cascinu S; Unit of Oncology, IRCCS-San Raffaele Scientific Institute, Università Vita-Salute, Milan, Italy.
  • Casadei-Gardini A; Unit of Oncology, IRCCS-San Raffaele Scientific Institute, Università Vita-Salute, Milan, Italy.
Target Oncol ; 16(5): 653-661, 2021 09.
Article em En | MEDLINE | ID: mdl-34491510
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Carcinoma Hepatocelular / Neoplasias Hepáticas Tipo de estudo: Clinical_trials / Diagnostic_studies / Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Carcinoma Hepatocelular / Neoplasias Hepáticas Tipo de estudo: Clinical_trials / Diagnostic_studies / Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article